retatrutide phase 2 trial type 2 diabetes results 2024 What Are the New Weight Loss Medications? Efficacy and safety of retatrutide,

What Theyre FDA-Approved For Currently, GLP-1 medications are approved for: Type 2 diabetes Obesity and weight management Reducing cardiovascular risk in people with heart or kidney disease MASH (metabolic-associated steatohepatitis) , formerly called NASH, a type of fatty liver disease Microdosing: What It Means Microdosing usually refers to staying at a very low dosesay, 0.25 mg of semaglutidelong-term, rather than gradually increasing to the therapeutic dose

In the gut, intraepithelial lymphocytes express high levels of GLP-1 receptors and can influence broader immune responses

Healthy eating habits, regular physical activity, and behavioral support play a critical role in keeping weight off

1 Based on actual data from approximately 17,000 patients at week 17 of the Kaiser Permanente Northern Californias 82-week long Medical Weight Management program

Safe & sustainable weight loss based on science

Mindfulness, meditation, yoga, or other relaxation practices complement Retatrutides anti-inflammatory effects